• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病与心血管疾病的共同遗传背景:一篇综述

A Common Genetic Background for Psoriasis and Cardiovascular Diseases: A Narrative Review.

作者信息

Lazar Andrada-Luciana, Romana Vulturar Cleopatra, Sitar-Tăut Adela-Viviana, Suharoschi Ramona, Orășan Olga Hilda, Chiș Adina Ancuța, Fodor Adriana, Tiperciuc Brîndușa, Login Cezar, Cozma Angela

机构信息

Internal Medicine Department 4th Medical Clinic "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca Romania.

Dermatology Department Integrated Ambulatory - Infectious Diseases Clinical Hospital Cluj-Napoca Romania.

出版信息

Health Sci Rep. 2025 Aug 13;8(8):e71128. doi: 10.1002/hsr2.71128. eCollection 2025 Aug.

DOI:10.1002/hsr2.71128
PMID:40809699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12344513/
Abstract

BACKGROUND AND AIMS

Psoriasis is an immune-mediated disease affecting primarily the skin and joints, but which also has systemic implications. There are assumptions about a common genetic background between psoriasis and cardiovascular diseases. This narrative review aims to provide an overview of the existing data regarding the IL-23 rs2066808, IL-23R rs2201841, IL-17RA rs4819554, and IL-17A rs2275913 polymorphisms and their link to psoriasis and cardiovascular diseases.

METHODS

PubMed, Web of Science, Scopus, and "SNPedia" searches were conducted to identify the relevant studies between 2007 and 2025 that investigated the association between psoriasis, cardiovascular diseases, and the IL-23 rs2066808, IL-23R rs2201841, IL-17RA rs4819554, and IL17A rs2275913 polymorphisms.

RESULTS

The existing data are conflicting. The polymorphisms could be implicated in psoriasis onset, disease susceptibility, and treatment response. Some of them are also linked to coronary artery disease. Contradictory data could result from the heterogeneity of the population included in the studies and the laboratory techniques used for polymorphism determination.

CONCLUSION

The interplay between IL-17, IL-23, and genetic polymorphisms illustrates a complex landscape in psoriasis and its associated comorbidities. More standardized case-control studies are needed to confirm this hypothesis. Moreover, extensive studies in diverse populations would be important to clarify these relationships and the potential implications for treatment and management.

摘要

背景与目的

银屑病是一种免疫介导的疾病,主要影响皮肤和关节,但也有全身影响。有观点认为银屑病与心血管疾病存在共同的遗传背景。本叙述性综述旨在概述关于白细胞介素-23(IL-23)rs2066808、白细胞介素-23受体(IL-23R)rs2201841、白细胞介素-17A受体(IL-17RA)rs4819554和白细胞介素-17A(IL-17A)rs2275913基因多态性及其与银屑病和心血管疾病关联的现有数据。

方法

在PubMed、科学网、Scopus和“SNPedia”中进行检索,以识别2007年至2025年间研究银屑病、心血管疾病与IL-23 rs2066808、IL-23R rs2201841、IL-17RA rs4819554和IL-17A rs2275913基因多态性之间关联的相关研究。

结果

现有数据相互矛盾。这些基因多态性可能与银屑病的发病、疾病易感性和治疗反应有关。其中一些还与冠状动脉疾病有关。矛盾的数据可能源于研究中纳入人群的异质性以及用于基因多态性测定的实验室技术。

结论

IL-17、IL-23与基因多态性之间的相互作用在银屑病及其相关合并症中呈现出复杂的情况。需要更多标准化的病例对照研究来证实这一假设。此外,在不同人群中进行广泛研究对于阐明这些关系以及对治疗和管理的潜在影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ce/12344513/dd04c1d0e283/HSR2-8-e71128-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ce/12344513/b6b4e06d73f8/HSR2-8-e71128-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ce/12344513/dd04c1d0e283/HSR2-8-e71128-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ce/12344513/b6b4e06d73f8/HSR2-8-e71128-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ce/12344513/dd04c1d0e283/HSR2-8-e71128-g002.jpg

相似文献

1
A Common Genetic Background for Psoriasis and Cardiovascular Diseases: A Narrative Review.银屑病与心血管疾病的共同遗传背景:一篇综述
Health Sci Rep. 2025 Aug 13;8(8):e71128. doi: 10.1002/hsr2.71128. eCollection 2025 Aug.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD011535. doi: 10.1002/14651858.CD011535.pub7.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

本文引用的文献

1
Assessment of Subclinical Atherosclerosis in Patients with Psoriasis Using Echocardiographic Coronary Flow Reserve Parameters: A Systematic Review and Meta-Analysis.使用超声心动图冠状动脉血流储备参数评估银屑病患者的亚临床动脉粥样硬化:一项系统评价和荟萃分析。
Br J Hosp Med (Lond). 2025 Feb 25;86(2):1-16. doi: 10.12968/hmed.2024.0618. Epub 2025 Feb 10.
2
Vascular Cell Adhesion Molecule 1 and E-Selectin as Potential Cardiovascular Risk Biomarkers in Psoriasis.血管细胞黏附分子1和E-选择素作为银屑病潜在的心血管风险生物标志物
Int J Mol Sci. 2025 Jan 18;26(2):792. doi: 10.3390/ijms26020792.
3
Subclinical Myocardial Dysfunction Assessment Using Speckle Tracking Echocardiography in Patients With Psoriasis: A Pilot Meta-Analysis.
银屑病患者中使用斑点追踪超声心动图评估亚临床心肌功能障碍:一项初步的荟萃分析。
Clin Cardiol. 2024 Dec;47(12):e70047. doi: 10.1002/clc.70047.
4
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis.与传统抗银屑病药物或阿普米司特不同,生物治疗可降低银屑病患者的死亡风险和心血管疾病风险。
EBioMedicine. 2025 Jan;111:105485. doi: 10.1016/j.ebiom.2024.105485. Epub 2024 Dec 6.
5
Association of interleukin-17F (rs763780) single nucleotide polymorphism with multiple sclerosis and optic neuritis.白细胞介素-17F(rs763780)单核苷酸多态性与多发性硬化症和视神经炎的关联。
Sci Rep. 2024 Jun 13;14(1):13643. doi: 10.1038/s41598-024-62736-2.
6
Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis.综述:对银屑病发病机制的当代多面洞察
J Pers Med. 2024 May 16;14(5):535. doi: 10.3390/jpm14050535.
7
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.心血管问题的考虑因素及对银屑病治疗的影响:最新综述。
Vasc Health Risk Manag. 2024 May 10;20:215-229. doi: 10.2147/VHRM.S464471. eCollection 2024.
8
Association between psoriasis and atrial fibrillation: A Systematic review and meta-analysis.银屑病与心房颤动之间的关联:一项系统评价与荟萃分析。
Curr Probl Cardiol. 2024 Jun;49(6):102538. doi: 10.1016/j.cpcardiol.2024.102538. Epub 2024 Mar 21.
9
Structural Basis for p19 Targeting by Anti-IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis.抗白细胞介素-23生物制剂靶向p19的结构基础:与银屑病短期和长期疗效的相关性
JID Innov. 2024 Jan 20;4(2):100261. doi: 10.1016/j.xjidi.2024.100261. eCollection 2024 Mar.
10
Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study.生物制剂治疗部分减轻了合并症对银屑病患者全因死亡率的负面影响:一项真实世界的病例对照研究。
J Am Acad Dermatol. 2024 Jul;91(1):43-50. doi: 10.1016/j.jaad.2024.01.078. Epub 2024 Feb 20.